BVF INC/IL Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001056807

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2024 · 62 positions · Total reported value $3.64B · Top-10 concentration 62.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 34.8% · 5 new · 9 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.0% · vs SPY +11.2% · Prev Value $3.14B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2024 13F filing, BVF INC/IL disclosed 62 equity positions with a combined reported value of $3.64B. The filing implies a focused portfolio: its ten largest positions account for 62.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were MLTX ($1.09B), KYMR ($207.50M), RVMD ($192.77M). By sector, the heaviest allocations are Health Care 85.2%, Materials 0.1%. Versus the prior quarter, allocation shifted toward Health Care (+1.5pp) and away from Other (-1.5pp).

Versus the prior quarter, BVF INC/IL opened 5 new positions, trimmed 9 and fully exited 2, a turnover rate of 34.8% of positions. The portfolio's overlap with the prior quarter was 83% of names.

The largest new positions opened in Q1 2024 were CGON ($82.72M), IMUX ($11.75M).

Of the 2 positions fully exited versus the prior quarter, the largest were AXSM ($157.68M), CNTA ($69.85M), RLAY ($43.71M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • CGON CG ONCOLOGY INC · $82.72M
  • IMUX IMMUNIC INC · $11.75M

Fully Exited (vs previous quarter)

  • AXSM AXSOME THERAPEUTICS INC. · prev qtr: $157.68M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $69.85M
  • RLAY RELAY THERAPEUTICS INC · prev qtr: $43.71M
  • XENE XENON PHARMACEUTICALS INC · prev qtr: $41.00M
  • SLN SILENCE THERAPEUTICS PLC · prev qtr: $26.20M
  • SYRE SPYRE THERAPEUTICS INC · prev qtr: $14.79M
  • STRO SUTRO BIOPHARMA INC · prev qtr: $14.36M · history
  • ITOS ITEOS THERAPEUTICS INC · prev qtr: $13.79M

Insider Transactions (Form 4)

Latest BVF INC/IL buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-14 U XOMA Royalty Corp 772,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 412,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 2,773,545 — SEC filing
2026-07-14 U XOMA Royalty Corp 3,635,758 — SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 51,858 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 113,289 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 627,597 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 837,914 $106.50 SEC filing

All insider transactions →

Fund Profile

BVF INC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 44 positions worth $3.91B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 44 positions · $3.91B reported value (Q2 2026)
  • Top 10 holdings = 65.6% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 14.2%
  • Average position size: $88.89M

Sector Tilt

  • Health Care 91.6%
  • Financials 0.1%
  • Materials 0.0%
  • (classified holdings cover 92% of value)

Quarterly Activity

  • Q2 2026: 5 new, 6 added, 9 reduced, 2 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 85.2%
Materials 0.1%
Other 14.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 21.75M $1.09B 30.04%
30.04%
Hold
2 5.16M $207.50M 5.71%
5.71%
Hold
3 5.98M $192.77M 5.30%
5.30%
Hold
4 3.92M $124.97M 3.44%
3.44%
Reduce
5 10.40M $110.87M 3.05%
3.05%
Hold
6 2.92M $109.93M 3.02%
3.02%
Reduce
7 4.37M $109.78M 3.02%
3.02%
Hold
8 3.76M $108.66M 2.99%
2.99%
Reduce
9 2.43M $105.28M 2.89%
2.89%
Hold
10 9.14M $103.42M 2.84%
2.84%
Hold
11 4.79M $102.09M 2.81%
2.81%
Reduce
12 3.63M $87.39M 2.40%
2.40%
Hold
13 1.88M $82.72M 2.27%
2.27%
New
14 4.66M $76.44M 2.10%
2.10%
Add
15 8.75M $74.28M 2.04%
2.04%
Hold
16 5.87M $61.75M 1.70%
1.70%
Hold
17 1.86M $60.01M 1.65%
1.65%
Reduce
18 3.20M $54.47M 1.50%
1.50%
Hold
19 1.17M $52.79M 1.45%
1.45%
Reduce
20 1.16M $51.00M 1.40%
1.40%
Reduce
21 7.00M $50.19M 1.38%
1.38%
Hold
22 10.33M $48.67M 1.34%
1.34%
Hold
23 4.05M $47.11M 1.29%
1.29%
Hold
24 1.88M $44.62M 1.23%
1.23%
Hold
25 14.57M $43.13M 1.19%
1.19%
Hold
26 4.37M $41.21M 1.13%
1.13%
Hold
27 2.25M $38.16M 1.05%
1.05%
Hold
28 1.52M $35.99M 0.99%
0.99%
Hold
29 812.99K $34.84M 0.96%
0.96%
Hold
30 2.74M $28.90M 0.80%
0.80%
Hold
31 9.54M $28.63M 0.79%
0.79%
Hold
32 2.99M $23.74M 0.65%
0.65%
Hold
33 16.55M $20.86M 0.57%
0.57%
Add
34 1.69M $19.89M 0.55%
0.55%
Hold
35 750.00K $16.24M 0.45%
0.45%
Hold
36 6.60M $14.38M 0.40%
0.40%
Hold
37 2.31M $11.86M 0.33%
0.33%
Hold
38 3.85M $11.75M 0.32%
0.32%
Reduce
39 8.90M $11.75M 0.32%
0.32%
New
40 2.00M $10.56M 0.29%
0.29%
Hold
41 4.33M $8.91M 0.24%
0.24%
Hold
42 650.00K $8.63M 0.24%
0.24%
Hold
43 4.77M $6.77M 0.19%
0.19%
Hold
44 6.86M $6.31M 0.17%
0.17%
Hold
45 1.81M $6.18M 0.17%
0.17%
Hold
46 1.20M $5.73M 0.16%
0.16%
Add
47 3.61M $4.98M 0.14%
0.14%
Add
48 945.40K $4.92M 0.14%
0.14%
Hold
49 917.83K $4.17M 0.12%
0.12%
Reduce
50 1.69M $4.05M 0.11%
0.11%
Reduce

FAQ

What did BVF INC/IL buy in 2024-Q1?

In its 2024-Q1 13F filing, BVF INC/IL reported 62 equity positions worth $3.64B in aggregate; its largest disclosed positions were MLTX ($1.09B), KYMR ($207.50M), RVMD ($192.77M).

How large is BVF INC/IL's portfolio?

BVF INC/IL reported $3.64B of long equity holdings across 62 positions as of 2024-Q1. Top-10 holdings account for 62.3% of reported value.

What is BVF INC/IL's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bvf-inc-il/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →